THE Therapeutic Goods Administration (TGA) warns that Ballerina Anti-Obesity capsules pose a serious health risk, containing banned substances phenolphthalein and sibutramine.
A second alert advises concerns over liver toxicity have seen Arthrem capsules withdrawn from the market.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Sep 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Sep 19
